Objective: The aim of this study was to determine whether preoperative MRI has an impact on surgical planning in breast cancer patients. Tumor extent and molecular breast cancer subtypes were evaluated. Methods: This was a single-center study including 137 female patients with a first diagnosis of invasive breast cancer. Each patient had a standard clinical preoperative workup and an additional breast MRI. The interdisciplinary tumor board made written recommendations regarding the surgical therapy of each patient with and without the knowledge of the MRI findings. Results: The addition of MRI led to changes in surgical recommendations in 32 (23%) of the 137 patients. The highest rate of change in surgical therapy recommendations was observed in patients with multifocal tumors (53%). Molecular subtype had no influence on the changes in surgical therapy recommendations (p = 0.8). Conclusions: Patients with multifocal breast tumors were more likely to have a change in surgical therapy following MRI.